Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25503494 | 1.00 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7563649 | 1.00 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL25503299 | 1.00 | L3MBTL1 (0.60) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL22073061 | 0.94 | L3MBTL1 (0.66) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7154526 | 0.93 | L3MBTL1 (0.67) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7155230 | 0.93 | L3MBTL1 (0.67) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7145707 | 0.93 | L3MBTL1 (0.67) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7153425 | 0.93 | L3MBTL1 (0.67) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL7147270 | 0.93 | L3MBTL1 (0.67) | L3MBTL1KMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL25502819 | 0.91 | L3MBTL1 (0.55) | L3MBTL1KMT2AMEN1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151051-A1 | METAL-CARBOHYDRATE COMPLEX | ARCZONE K.K. (JP) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151051-A1 | METAL-CARBOHYDRATE COMPLEX | SLC2A1, SLC5A1, SLC2A3 | L3MBTL1 758/4885KMT2A 4199/4885MEN1 1148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.